FindTrial
Sign In

SUMMIT RISE Study of Acute Ischemic Stroke Patients

SUMMIT RISE Study of Acute Ischemic Stroke Patients Evaluating the Route 92 Medical Reperfusion Systems.

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07436156
Enrollment
500
Registered
2026-02-27
Start date
2026-02-12
Completion date
2029-11-30
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Ischemic Stroke

Keywords

Acute Ischemic Stroke

Brief summary

SUMMIT RISE Study of Acute Ischemic Stroke Patients

Detailed description

SUMMIT RISE Study of Acute Ischemic Stroke Patients Evaluating the Route 92 Medical Reperfusion Systems.

Interventions

DEVICERoute 92 Medical Reperfusion Systems

Mechanical thrombectomy with the Route 92 Medical Reperfusion Systems

Sponsors

Route 92 Medical, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Acute ischemic stroke patient initially treated (first pass) with a Route 92 Medical Reperfusion System * Informed consent completed and documented within 72 hours following thrombectomy procedure * Endovascular treatment initiated (defined as time of groin puncture) within 8 hours from time last known well * Age ≥ 18 years

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Periprocedural eTICI measurement of revascularizationPeriproceduralRevascularization status checklist

Countries

United States

Contacts

CONTACTRenee Kochevar Vice President, Clinical Research, PhD, ALM
reneek@r92m.com650-581-1179

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026